BOOKMARK
  • Korean|
  • Chinese|
  • Japanese|
  • Vietnamese
본문내용 바로가기

Aju Business Daily

SEARCH
World's top technology exhibition CES 2021
  • ECONOMY
  • ENTERTAINMENT
  • IT
  • South Korea
  • North Korea
  • WORLD
  • SPORTS
  • LIFESTYLE
  • AUTO MOTIVE
  • OPINION
  • PEOPLE
  • MILITARY
Home > Health > article

Natural killer cells found to be effective in killing cells infected with new coronavirus

Lim Chang-won Reporter(cwlim34@ajunews.com) | Posted : August 18, 2020, 13:48 | Updated : August 18, 2020, 13:48
  • 트위터
  • 페이스북
  • 웨이보

[Gettyimages Bank]

SEOUL -- Natural killer cells were confirmed to be effective in killing cells infected with a new coronavirus in a study conducted by GC Labcell, a manufacturer of cell therapy products in South Korea, which promotes its natural killer (NK) cell treatment as next-generation immuno-oncology.

For its joint study with a research team at Chungbuk National University College of Medicine, GC Labcell said in a statement that it has reacted NK cells to cells infected with the coronavirus and those not infected to check their efficacy. NK cells, which are innate immune cells, attack cancer cells or viruses.

NK cells were found to be seven to eight times more active than a comparison group in virus-infected cells, GC Labcell said, adding the secretion of IFN-g (interferon-gamma), a key indicator of immunity assessment, also increased by about 1.5 times. The study means that NK cells directly or indirectly induce the apoptosis of cells infected with the coronavirus

"This study has proven multiple effects, including anti-cancer effects in NK cells as well as antiviral efficacy," said GC Labcell's cell therapy research center head Hwang Yu-kyung. "We will pursue global clinical trials by accumulating meaningful pre-clinical data through follow-up research."

GC Labcell said its NK cell treatment, MG4101, can be used without any side effects to patients because of its high purity. In collaboration with KLEO Pharmaceuticals, a US biotech company, GC Labcell is developing a complex treatment that uses an antibody-inducing substance to curb the spread of COVID-19 and remove infected cells with NK cells.

  • Lim Chang-won Reporter
  • email : cwlim34@ajunews.com
© Aju Business Daily & www.ajunews.com Copyright: All materials on this site may not be reproduced, distributed, transmitted, displayed, published or broadcast without the authorization from the Aju News Corporation.
  • twitter
  • facebook
  • weibo
  • link copy
  • LIST
  • TOP

Related news

  • .LSK Global PS to conduct third-stage clinical test of Chinese vaccine in Bangladesh.
    LSK Global PS to conduct third-stage clinical test of Chines…
  • .GC Pharma shares up on expected consignment production deal with Moderna .
    GC Pharma shares up on expected consignment production deal …
  • .LG Chem secures $80 mln deal to supply poliovirus vaccine thru UNICEF.
    LG Chem secures $80 mln deal to supply poliovirus vaccine th…
  • .Expert upholds masks as better than vaccines in preventing COVID-19 infection.
    Expert upholds masks as better than vaccines in preventing C…
  • .Celltrion leaves door open for consignment production of COVID-19 vaccines.
    Celltrion leaves door open for consignment production of COV…

Real Time Photo News

  • .Singer IU drops teaser image for upcoming full album.

    Singer IU drops teaser image for upcoming full album

  • .Cube Entertainment partners with web comics company to create online video content.

    Cube Entertainment partners with web comics company to create online video content

  • .Sci-fi film starring Song Joong-ki to be reelased on Netflix in February.

    Sci-fi film starring Song Joong-ki to be reelased on Netflix in February

  • .Actor Kim Soo-hyun to star in S. Korean remake of British TV drama series Criminal Justice.

    Actor Kim Soo-hyun to star in S. Korean remake of British TV drama series 'Criminal Justice'

  • .CJ ENM partners with NCSoft to roll out new digital content for global market.

    CJ ENM partners with NCSoft to roll out new digital content for global market

Latest News

more+

  • Singer IU drops teaser image for upcoming full album
  • Hyundai to complete construction of fuel cell production plant in China in 2022
  • Seoul builds solar power plant on idle land near urban expressway
  • Samsung showcases new Galaxy S21 smartphone models
  • Southern city launches joint research project to develop heavy-duty flying taxi drone
Aju Business Daily
  • ABOUT US
  • CONTACT US
  • PRIVACY STATEMENT
  • Copyright Policy

Address : Aju News Corporation LEEMA Building, 11th floor, 42, Jong-ro 1-gil, Jongno-gu, Seoul.    Mail : swatchsjp@ajunews.com

Copyright ⓒ 2016 By Ajunews Corporation, All Rights Reserved.

Mobile view